A general IGF-I overexpression effectively rescued somatic growth and bone deficiency in mice caused by growth hormone receptor knockout

Growth Factors

Volumn 27, Issue 6, 2009, Pages 438-447

  De Jesus, Kristine ^a   Wang, Xiao ^a,b   Liu, Jun Li ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Montreal Diabetes Research Centre   (Canada)

Author keywords

Adipocyte; Adiposity; Bone mineralization; Hypoglycemia; Insulin sensitivity

Indexed keywords

GLUCOSE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY GROWTH; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; CONTROLLED STUDY; CROSS BREEDING; FEMALE; FEMUR; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HORMONE RESISTANCE; LEAN BODY WEIGHT; LUMBAR SPINE; MALE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ADIPOCYTES; ADIPOSITY; ANIMALS; BODY WEIGHT; BONE DISEASES; CALCIFICATION, PHYSIOLOGIC; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HYPOGLYCEMIA; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, SOMATOTROPIN; UP-REGULATION;

MUS; MUS MUSCULUS;

EID: 70450175394     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903299270     Document Type: Article

References (28)

1. Bachrach LK, Marcus R, Ott SM, Rosenbloom AL, Vasconez O, Martinez V, Martinez AL, Rosenfeld RG, Guevara-Aguirre J. 1998. Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency. J Bone Miner Res 13:415-421.
2. Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL, D'Ercole AJ. 1990. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 127:1033-1040.
3. Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE, and for the GHISCG. 2007. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 92:902-910.
4. Duan C, Xu Q. 2005. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol 142:44-52.
5. Kaplan SA, Cohen P. 2007. Review: The somatomedin hypothesis 2007: 50 years later. J Clin Endocrinol Metab 92:4529-4535.
6. Kim H, Barton E, Muja N, Yakar S, Pennisi P, Leroith D. 2005. Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo. Endocrinology 146:1772-1779.
7. Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N. 2006. LongtermIGF- I treatment of children with Laron syndrome increases adiposity. Growth Horm IGF Res 16:61-64.
8. Le Roith D, Bondy C, Yakar S, Liu J-L, Butler A. 2001. The somatomedin hypothesis: 2001. Endocr Rev 22:53-74.
9. Liu JL, LeRoith D. 1999. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 140:5178-5184.
10. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72.
11. Liu JL, Yakar S, LeRoith D. 2000. Mice deficient in liver production of insulin-like growth factor I display sexual dimorphism in growth hormone-stimulated postnatal growth. Endocrinology 141:4436-4441.
12. Liu JL, Coschigano KT, Robertson K, Lipsett M, Guo Y, Kopchick JJ, Kumar U, Liu YL. 2004. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab 287:E405-E413.
13. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD. 1988. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123:2827-2833.
14. Norrelund H. 2005. The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm IGF Res 15:95-122.
15. Ohneda K, Ulshen MH, Fuller CR, D'Ercole AJ, Lund PK. 1997. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology 112: 444-454.
16. Pescovitz OH, Eugster EA. 2004. Pediatric endocrinology: Mechanisms, manifestations, and management. Philadelphia, PA: Lippincott.
17. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts- Meek S, Dalton D, Gillett N, Stewart TA. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev 7: 2609-2617.
18. Robertson K, Kopchick JJ, Liu JL. 2006. Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice. Am J Physiol Endocrinol Metab 291:E491-E498.
19. Robertson K, Lu Y, De Jesus K, Li B, Su Q, Lund PK, Liu JL. 2008. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes. Am J Physiol Endocrinol Metab 294:E928-E938.
20. Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA. 2000. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 106:1095-1103.
21. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C. 1999. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96: 7088-7092.
22. Sjogren K, Bohlooly YM, Olsson B, Coschigano K, Tornell J, Mohan S, Isaksson OG, Baumann G, Kopchick J, Ohlsson C. 2000. Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor 2 /2 mice. Biochem Biophys Res Commun 267:603-608.
23. Stratikopoulos E, Szabolcs M, Dragatsis I, Klinakis A, Efstratiadis A. 2008. The hormonal action of IGF1 in postnatal mouse growth. Proc Natl Acad Sci USA 105:19378-19383.
24. Wallenius K, Sjogren K, Peng X-D, Park S, Wallenius V, Liu J-L, Umaerus M, Wennbo H, Isaksson O, Frohman L, Kineman R, Ohlsson C, Jansson J-O, Liver-derived IGF-I, regulates GH. 2001. secretion at the pituitary level in mice. Endocrinology 142: 4762-4770.
25. Wu Y, Sun H, Yakar S, Leroith D. 2009. Elevated levels of IGF-1 in serum rescue the severe growth retardation of IGF-1 null mice. Endocrinology 150(9):4395-4403.
26. Yakar S, Liu JL, Stannard B, Butler A, AcciliD, Sauer B, LeRoithD. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96: 7324-7329.
27. Ye P, Carson J, D'Ercole AJ. 1995. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. Journal of Neuroscience 15:7344-7356.
28. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ. 1997. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220.